Arbutus Biopharma Corp operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arbutus Biopharma Corp with three other pharmaceutical manufacturers in North America: Lineage Cell Therapeutics Inc of the United States (2018 sales of $4.99 million of which 100% was Synthetic Solutions), Erytech Pharma SA of the United States ($5.24 million of which 100% was Pharmacy), and Titan Pharmaceuticals Inc which is also based in the United States ($6.62 million of which 100% was Development of Pharmaceutical Products).

Sales Analysis. During the year ended December of 2018, sales at Arbutus Biopharma Corp were C$7.73 million (US$5.83 million). This is a sharp decrease of 44.2% versus 2017, when the company's sales were C$13.86 million.